WuXi AppTec Co., Ltd. (SHA:603259)

Market Cap	169.84B
Revenue (ttm)	39.59B
Net Income (ttm)	11.18B
Shares Out	2.87B
EPS (ttm)	3.24
PE Ratio	15.72
Forward PE	13.75
Dividend	0.98 (1.66%)
Ex-Dividend Date	Jun 26, 2024

Volume	10,128,394
Average Volume	43,433,142
Open	60.60
Previous Close	59.06
Day's Range	59.78 - 60.61
52-Week Range	36.36 - 70.68
Beta	0.84
RSI	53.69
Earnings Date	Apr 28, 2025

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2000
• Employees: 39,414
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603259

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.